Generic drug and API manufacturer serving Central and Eastern Europe
Polpharma is a Starogard Gdański–based generics and active pharmaceutical ingredient producer with a footprint across Central and Eastern Europe and Kazakhstan. Its stack pairs plant-floor control (Siemens S7, TIA Portal, MES, Maximo) with Azure, OCI, Palo Alto and Fortinet, and security is one of its larger hiring areas, focused on OT hardening, virtual patching and AI anomaly detection in industrial traffic.
Notable leadership hires: Validation Lead, Head of Procurement, Production Team Lead
Polpharma, founded in 1935, manufactures generic medicines and active pharmaceutical ingredients. It is privately held, headquartered in Starogard Gdański, Poland, and employs between 1,001 and 5,000 people. The company operates in Central and Eastern Europe and Kazakhstan, and it also runs a B2B channel for pharmaceutical ingredients. Current hiring is concentrated in Poland and covers manufacturing, security, engineering, research and commercial functions. Open leadership roles include validation, procurement and production team leads.
Polpharma runs SAP, SAP Ariba and Oracle alongside Azure and OCI with Terraform and Bicep. Plant systems include Siemens S7, TIA Portal, MES and Maximo. Analytics is built on Power BI and Microsoft Fabric, and Palo Alto and Fortinet cover security.
Yes. Security is one of Polpharma's larger hiring areas in Poland. The work centers on OT network security, network access control, ransomware-resistant backups and multicloud security standards.
Polpharma is implementing AI anomaly detection for industrial traffic and building multicloud secure architecture standards. It is also running API and oligonucleotide development projects and developing new reporting tools.
Other companies in the same industry, closest in size
Polpharma's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.